We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+0.78%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$222M
AUM Growth
-$2.35M
(-1%)
Cap. Flow
-$2.04M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
69.61%
Holding
40
New
–
Increased
2
Reduced
6
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$899K |
| 2 |
Verizon
VZ
|
+$37K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.66M |
| 2 |
Progressive
PGR
|
+$790K |
| 3 |
Stryker
SYK
|
+$289K |
| 4 |
Microsoft
MSFT
|
+$188K |
| 5 |
Organon & Co
OGN
|
+$45.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.11% |
| 2 | Healthcare | 28.94% |
| 3 | Technology | 21.82% |
| 4 | Consumer Staples | 3.71% |
| 5 | Industrials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Progressive
PGR
$122B
| $75.2M | 33.82% |
567,757
-5,896
| -1% | -$790K |
|
|
2
Stryker
SYK
$131B
| $20.5M | 9.22% |
67,130
-1,000
| -1% | -$289K |
|
|
3
Microsoft
MSFT
$3.62T
| $13.9M | 6.27% |
40,900
-600
| -1% | -$188K |
|
4
Apple
AAPL
$4.45T
| $10.7M | 4.8% |
54,940
| – | – |
|
5
Merck
MRK
$315B
| $8.02M | 3.61% |
69,500
| – | – |
|
6
Johnson & Johnson
JNJ
$613B
| $6.43M | 2.89% |
38,838
| – | – |
|
7
Thermo Fisher Scientific
TMO
$213B
| $5.73M | 2.58% |
10,985
| – | – |
|
8
AbbVie
ABBV
$433B
| $4.97M | 2.24% |
36,900
| – | – |
|
|
MRSH
9
Marsh
MRSH
$92B
| $4.8M | 2.16% |
25,500
| – | – |
|
10
Applied Materials
AMAT
$411B
| $4.52M | 2.04% |
31,300
| – | – |
|
11
Nucor
NUE
$59.5B
| $4.5M | 2.02% |
27,435
| – | – |
|
12
Intel
INTC
$459B
| $4.35M | 1.96% |
129,950
| – | – |
|
13
Cisco
CSCO
$457B
| $4.28M | 1.93% |
82,700
| – | – |
|
|
14
Pfizer
PFE
$143B
| $4.02M | 1.81% |
109,708
+23,100
| +27% | +$899K |
|
15
Unilever
UL
$137B
| $3.96M | 1.78% |
67,591
| – | – |
|
16
IBM
IBM
$213B
| $3.96M | 1.78% |
29,564
| – | – |
|
17
Emerson Electric
EMR
$86.7B
| $3.89M | 1.75% |
43,000
| – | – |
|
18
Abbott
ABT
$185B
| $3.56M | 1.6% |
32,700
| – | – |
|
19
Bristol-Myers Squibb
BMY
$134B
| $3.47M | 1.56% |
54,300
| – | – |
|
20
United Parcel Service
UPS
$90.8B
| $2.68M | 1.21% |
14,950
| – | – |
|
21
Procter & Gamble
PG
$338B
| $2.49M | 1.12% |
16,400
| – | – |
|
22
Philips
PHG
$25.6B
| $2.2M | 0.99% |
113,544
-7
| -0% | -$122 |
|
23
Agilent Technologies
A
$39.5B
| $2.15M | 0.97% |
17,900
| – | – |
|
24
Corning
GLW
$126B
| $1.98M | 0.89% |
56,400
| – | – |
|
25
GSK
GSK
$103B
| $1.89M | 0.85% |
52,960
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
FI
Bonness Enterprises's Q2 2023 Portfolio in Review
As of Q2 2023, Bonness Enterprises held 40 positions worth $222M, down 1% from $225M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 0%. Bonness Enterprises opened no new positions and made no exits, leaving the 40-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 40% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises added most to Pfizer in Q2 2023, an estimated $899K increase.
- Bonness Enterprises's biggest Q2 2023 reduction was Oracle, cutting an estimated $1.66M.
- Bonness Enterprises's ten largest holdings make up 70% of its $222M portfolio in Q2 2023.
- Bonness Enterprises opened 0 new positions and closed 0 in Q2 2023.
- Bonness Enterprises's portfolio value fell 1% quarter-over-quarter to $222M.
Based on Bonness Enterprises's 13F filing for Q2 2023, filed 14 Jul 2023.